REFERENCES
1. Meier B. A cardiologist’s perspective on patent foramen ovale-associated conditions. Cardiol Clin. 2024;42:547-57.
2. Vidal-Calés P, Llull L, Lanthier S, et al. Patent foramen ovale closure in older patients with cryptogenic stroke: current evidence and next steps. Structural Heart. 2025;9:100699.
3. Ibrahim R, Pathangey G, Pham HN, et al. Patent foramen ovale closure for primary prevention of stroke. CJC Open. 2026;8:493-7.
4. Mazzucco S, Li L, Rothwell PM. Prognosis of cryptogenic stroke with patent foramen ovale at older ages and implications for trials: a population-based study and systematic review. JAMA Neurol. 2020;77:1279.
5. Martinez C, Cohen AT, Bamber L, Rietbrock S. Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer. Thromb Haemostasis. 2014;112:255-63.
6. Vidal-Calés P, Houde C, Battistolo Q, et al. Twenty-year follow-up after patent foramen ovale closure in patients with paradoxical embolism. JAMA Cardiol. 2026;11:383.
